| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.083 | 0.1 |